Found 16 clinical trials
Camrelizumab Combined With Radiotherapy and Chemotherapy for the Treatment of Recurrent or Metastatic Cervical Cancer
To evaluate the effectiveness and safety of camrelizumab combined with radiotherapy and chemotherapy for recurrent or metastatic cervical cancer
- 0 views
- 20 May, 2021
- 1 location
Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer (innovaTV 301)
This trial is being done to find out whether tisotumab vedotin works better than chemotherapy to treat cervical cancer. People in this study have cervical cancer that has spread to other parts of the body (metastatic) or has come back after being treated (recurrent). Participants in this trial will be …
- 3 views
- 19 Sep, 2023
- 11 locations
A Study of SHR-1701 Plus Platinum-containing Chemotherapy With or Without BP102 (Bevacizumab) as First-line Treatment in Cervical Cancer
, Recurrent, or Metastatic Cervical Cancer.
- 0 views
- 24 Apr, 2022
- 1 location
Ultrafractionated Radiation Therapy for Metastatic Cervical Cancer
To improve overall survival in patients with metastatic cervical cancer by loco-regional therapy with ultra-fractionated radiation therapy
- 0 views
- 16 Sep, 2023
- 1 location
Study of the SG001 Injection for Patients With Relapsed or Metastatic Uterine Cervical Cancer
This study is an open, single-arm, multicenter phase II study to investigate the efficacy and safety of SG001 for relapsed or metastatic uterine cervical cancer patients with PD-L1 positive
- 0 views
- 30 Nov, 2021
- 1 location
A Study of AK104 Plus Platinum-containing Chemotherapy±Bevacizumab as First-line Treatment for Persistent, Recurrent, or Metastatic Cervical Cancer
, Recurrent, or Metastatic Cervical Cancer
- 0 views
- 10 May, 2022
- 5 locations
Phase II Study of Stereotactic Body Radiation Therapy and Atezolizumab in the Management of Recurrent, Persistent, or Metastatic Cervical Cancer
in patients with recurrent, persistent, or metastatic cervical cancer.
- 38 views
- 11 Oct, 2022
- 2 locations
A Clinical Study to Explore the Efficacy and Safety of Tislelizumab in Combination With Bevacizumab and Chemotherapy in Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Efficacy and safety of Tislelizumab combined with Bevacizumab and chemotherapy in patients with persistent, recurrent or metastatic cervical cancer.
- 0 views
- 04 Oct, 2022
- 1 location
Pembrolizumab and Lenvatinib in Advanced Cervical Cancer
This is a phase II trial of combination therapy of pembrolizumab and lenvatinib in patients with locally advanced or metastatic cervical cancer that had failed first line of therapy. The
- 0 views
- 20 Aug, 2023
- 2 locations
Study of C-TIL052A Cell Therapy in Advanced Cervical Cancer (TIL)
A study that aimed to assess the safety and anti-tumor activity of C-TIL052A cell therapy in subjects with persistent, recurrent and/or metastatic cervical cancer.
- 0 views
- 04 Oct, 2022
- 2 locations
- 1
- 2